Fagron NV signed an agreement to acquire Parma Produkt Gyógyszergyártó Korlátolt Felelosségu Társaság.
close early January 2024.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
18.86 EUR | -0.11% | +0.43% | +13.55% |
Apr. 11 | Transcript : Fagron NV, Q1 2024 Sales/ Trading Statement Call, Apr 11, 2024 | |
Apr. 11 | Fagron Reports Revenue Results for the First Quarter Ended 31 March 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+13.55% | 1.5B | |
+33.13% | 709B | |
+30.77% | 595B | |
-2.23% | 367B | |
+20.23% | 334B | |
+4.95% | 289B | |
+14.23% | 239B | |
+9.03% | 211B | |
-3.44% | 203B | |
+8.57% | 171B |